España
India
Italia
대한민국
日本
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
India
Italia
대한민국
日本
  • Our Services
  • News
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Legal
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Forex
    Cannabis
    Commodities
    Binary Options
    Bonds
    Futures
    CME Group
    Global Economics
    Mining
    Previews
    Small-Cap
    Real Estate
    Penny Stocks
    Digital Securities
    Volatility
  • Options
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    From The Press
    Jim Cramer
    Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
  • Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks

Brinson Patrick


UPDATE: Brinson Patrick Initiates Coverage on MannKind
UPDATE: Brinson Patrick Initiates Vical at Market Outperform on Allovectin Potential
UPDATE: Brinson Patrick Downgrades ZIOPHARM Oncology to Market Perform on Palifosfamide Failure
UPDATE: Brinson Patrick Initiates Vical at Market Outperform on Allovectin Potential
UPDATE: Brinson Patrick Downgrades ZIOPHARM Oncology to Market Perform on Palifosfamide Failure
Brinson Patrick Reiterates Market Outperform on Novavax on Strong Finish to 2012
UPDATE: Brinson Patrick Initiates NeoStem at Market Outperform, Sees Strong Position in Cell-Based Therapy

Brinson Patrick Reiterates Market Outperform on Novavax on Strong Finish to 2012
|
UPDATE: Brinson Patrick Initiates NeoStem at Market Outperform, Sees Strong Position in Cell-Based Therapy
|
UPDATE: Brinson Patrick Initiates Zogenix at Market Putperform on Zophydro Prospects
|
UPDATE: Brinson Patrick Initiates Coverage on MannKind Corporation with Market Outperform Rating, $6 PT
|
Read More...

Brinson Patrick Recent News

Connect With Us

facebookinstagramlinkedintwitteryoutube

About Benzinga

  • About Us
  • Careers
  • Advertise
  • Contact Us

Market Resources

  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets

Trading Tools & Education

  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2025 Benzinga | All Rights Reserved